A dental device that provides for the entirely non-surgical management of early, cavitated dental lesions consisting of a ceramic wafer sized to cover the dental lesion and resin bonded to the tooth effectively encapsulating the dental lesion. The ceramic wafer may incorporate antimicrobial preparations, radiopaque markers, and/or silver diamine fluoride.

A processing material block of a complete denture includes; a disk body with a predetermined thickness; at least one positioning notch formed on a side of the disk body for installing/positioning a processing device; a horseshoe preform block disposed at an end apart from the disk body and having a height and first and second ends defined on opposite sides of the horseshoe preform block and being provided for the processing device to form a serrated arrangement structure; and plural tray preform blocks disposed at the first and second ends of the horseshoe preform block, each being higher than the horseshoe preform block. The structural type simulates the posterior margin of human teeth and is provided for the processing device to form the shape of the gum of the formed posterior margin of the teeth, and this structure can improve the stereoscopic and simulation levels of the finished product.

Disclosed are cement products, methods of forming cement using the cement product, and methods of using the cement product in orthopedic and dental applications. Generally, the disclosed cement product includes a first component and a second component. The first component comprises a polymerizable resin comprising ethylenic unsaturated double bond, a suitable glycidyl group and/or a suitable isocyanate group. The second component includes a compound comprising more than one type of amine selected from the group consisting of primary amine, secondary amines, tertiary amines and quaternary amines. Alternatively, the second component includes a compound comprising a suitable mercapto (SH) group, a hindered amine or a dimethylthiotoluenediamine (DMTDA). Optionally, the cement product includes a filler and/or a bioactive component to promote bone formation.

Disclosed are cement products, methods of forming cement using the cement product, and methods of using the cement product in orthopedic and dental applications. Generally, the disclosed cement product includes a first component and a second component. The first component comprises a polymerizable resin comprising ethylenic unsaturated double bond, a suitable glycidyl group and/or a suitable isocyanate group. The second component includes a compound comprising more than one type of amine selected from the group consisting of primary amine, secondary amines, tertiary amines and quaternary amines. Alternatively, the second component includes a compound comprising a suitable mercapto (SH) group, a hindered amine or a dimethylthiotoluenediamine (DMTDA). Optionally, the cement product includes a filler and/or a bioactive component to promote bone formation.

Provided is a curable composition including a polymerizable monomer component (A), a spherical filler (B) having an average particle size within the range of 230-1000 nm, and a polymerization initiator (C), wherein the curable composition is characterized by having a value (V) of less than 5 and a chroma (C) of 0.05 or higher in colorimetric values according to the Munsell Color System in colored light on a black background, and a value (V) of 6 or higher and a chroma (C) of less than 2 in colorimetric values according to the Munsell Color System in colored light on a white background, each of the values (V) and chroma (C) being measured using a color difference meter in a state in which a 1-mm-thick cured article has been formed.

Provided is a curable composition including a polymerizable monomer component (A), a spherical filler (B) having an average particle size within the range of 230-1000 nm, and a polymerization initiator (C), wherein the curable composition is characterized by having a value (V) of less than 5 and a chroma (C) of 0.05 or higher in colorimetric values according to the Munsell Color System in colored light on a black background, and a value (V) of 6 or higher and a chroma (C) of less than 2 in colorimetric values according to the Munsell Color System in colored light on a white background, each of the values (V) and chroma (C) being measured using a color difference meter in a state in which a 1-mm-thick cured article has been formed.

The present disclosure concerns a mineralized tissue adhesive or filler composition comprising an intermolecular crosslinked osteopontin protein for treating an exposed surface of a mineralized tissue. The mineralized tissue adhesive or filler composition can be added directly on the exposed surface of the mineralized tissue or on a layer of monodisperse OPN protein which has been deposited on the exposed surface of the mineralized tissue. The present disclosure also includes methods and kits of using the mineralized tissue adhesive or filler composition especially in dental applications. The present application also provides dental coatings, fillings, bondings and veneers comprising the mineralized tissue adhesive or filler composition described herein.

The present disclosure concerns a mineralized tissue adhesive or filler composition comprising an intermolecular crosslinked osteopontin protein for treating an exposed surface of a mineralized tissue. The mineralized tissue adhesive or filler composition can be added directly on the exposed surface of the mineralized tissue or on a layer of monodisperse OPN protein which has been deposited on the exposed surface of the mineralized tissue. The present disclosure also includes methods and kits of using the mineralized tissue adhesive or filler composition especially in dental applications. The present application also provides dental coatings, fillings, bondings and veneers comprising the mineralized tissue adhesive or filler composition described herein.

The present application describes fib-reinforced dental composites (FRCs), processes for producing and uses of, the fibre-reinforced dental composites. More particularly, the fibre-reinforced dental 5 composites described herein comprise a polymerisable resin and from about 0.5% to about 25% w/w of fibres having a diameter of from about 3 m to about 9 m and a length of from about 60 m to about 2 mm.

Disclosed herein are methods for creating opalescence in dental materials and restorations, compositions used in such methods, and the resultant dental materials and restorations. More particularly, the opalescence may be created by directly embedding opalescent particles into a matrix material. In some embodiments, photonic crystals are embedded in the dental material to achieve the opalescent effect. Photonic crystal particles may be embedded in dental materials matrices such as ceramics, composites, and polymers, and can generate opalescence in the materials. Some embodiments disclose compositions for applying the opalescence to a dental restoration.